NCT02442843

Brief Summary

This study is designed to identify changes in the brain that underlie symptoms of combat-related PTSD using brain imaging (fMRI). Then, the investigators will administer mild electrical stimulation to the side of the head (using a method called tDCS) in an attempt to reduce the symptoms of PTSD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started May 2015

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 13, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

August 31, 2018

Status Verified

August 1, 2018

Enrollment Period

2.3 years

First QC Date

February 17, 2015

Last Update Submit

August 28, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional Connectivity changes as assessed by fMRI images

    Investigators will use the fMRI images taken from before and after tDCS to determine if the treatment intervention contributed to any changes within the neural networks associated with the symptoms of PTSD.

    Pre and post tDCS; typically within 4 weeks

Secondary Outcomes (8)

  • Symptomatic changes as assessed by structured questionnaires (PCL-C)

    Pre and post tDCS; typically within 4 weeks

  • Symptomatic changes as assessed by structured questionnaires (CAPS)

    Pre and post tDCS; typically within 4 weeks

  • Symptomatic changes as assessed by structured questionnaires (Hamilton Depression Rating Scale)

    Pre and post tDCS; typically within 4 weeks

  • Symptomatic changes as assessed by structured questionnaires (State-trait anxiety inventory)

    Pre and post tDCS; typically within 4 weeks

  • Cognitive changes as assessed by Neuropsychological testing

    Pre and post tDCS; typically within 4 weeks

  • +3 more secondary outcomes

Study Arms (3)

active tDCS

EXPERIMENTAL

Investigators will use cathodal tDCS to inhibit the brain regions that may be associated with symptoms of PTSD (temporal cortex). Active tDCS will be provided at 2 miliamps (mA) for 20 minutes (with gradual increase and withdraw of stimulation during the first and last minute).

Device: Active tDCS

sham tDCS

SHAM COMPARATOR

Participants randomized to the sham condition will receive stimulation during the first and final minutes of the 20 minute period (with gradual increase and removal of current during that time).

Device: Sham tDCS

Combat Controls

NO INTERVENTION

Participants without PTSD will undergo neuropsychological testing and a single fMRI scan.

Interventions

Participants will be randomized into active or sham stimulation in the first tDCS session. Participants will then have the option to complete 9 additional session of tDCS which will be active tDCS or a combination of active and sham tDCS in a non-randomized manner over two consecutive weeks. Each session will last 1 - 2 hours.

Also known as: mild brain stimulation, HD-tDCS
active tDCS
Sham tDCSDEVICE

Participants will be randomized into active or sham stimulation in the first tDCS session. Participants will then have the option to complete 9 additional session of tDCS which will be active tDCS or a combination of active and sham tDCS in a non-randomized manner over two consecutive weeks. Each session will last 1 - 2 hours.

Also known as: fake tDCS
sham tDCS

Eligibility Criteria

Age18 Years - 88 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male
  • Combat Veteran - both Veterans with and without PTSD will be included at different points in this study
  • Right-handed
  • Between the ages 18-88
  • Stable on medications for a minimum of 2 weeks

You may not qualify if:

  • a history of neurological disease (e.g., dementia, epilepsy, stroke, moderate - severe traumatic brain injury)
  • "severe" Axis I diagnoses (e.g., bipolar disorder, schizophrenia)
  • presence of Axis II disorders
  • current alcohol or drug abuse/dependence (in the past 8 weeks)
  • participants will also be excluded if they are not MRI compatible (assessed using the guidelines of the American College of Radiology)
  • Imminent risk of harm to self or others
  • history of HIV or sickle cell anemia, as these can cause neuropsychological issues .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan Neuropsychology Section

Ann Arbor, Michigan, 48105, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Benjamin Hampstead, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

February 17, 2015

First Posted

May 13, 2015

Study Start

May 1, 2015

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

August 31, 2018

Record last verified: 2018-08

Locations